Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 38,927 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

38,927 Papers indexed
963 Papers AI scored
38,927 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.

LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
LATEST PEDIATRIC CANCER PAPERS

Database feed

Last ingest 2026-10-05 09:15 AM
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

38927 results
C
Long-Term Outcome and Social-Intellectual Ability of Patients With Basal Ganglia Germinoma.
PMID 39922138 Published: 2025-01-16 Ingested: 2026-08-02 12:03 AM Pediatric neurology
AI -
Standard 64.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 64.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 44.0; sample size: 30.0; recency: 90.0; abstract quality: 100.0.

C
Clinical outcomes of adults with intracranial grade 1 and 2 ganglioglioma.
PMID 39884127 Published: 2025-01-29 Ingested: 2026-08-02 12:03 AM Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
AI -
Standard 64.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 64.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 44.0; sample size: 30.0; recency: 90.0; abstract quality: 100.0.

C
Long-term surgical outcomes and prognosis of cervical spinal hemangioblastomas.
PMID 39842158 Published: 2025-01-21 Ingested: 2026-08-02 12:03 AM Clinical neurology and neurosurgery
AI -
Standard 64.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 64.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 34.0; sample size: 50.0; recency: 90.0; abstract quality: 100.0.

C
Hepatocellular Carcinoma with Vascular Invasion Treated with Resin Yttrium-90 Transarterial Radioembolization Using Single Compartment Dosimetry.
PMID 39809884 Published: 2025-01-14 Ingested: 2026-08-02 12:03 AM Cardiovascular and interventional radiology
AI -
Standard 64.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 64.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 34.0; sample size: 50.0; recency: 90.0; abstract quality: 100.0.

C
A Rare Case of Salmonella Enteritidis Sinusitis.
PMID 39803127 Published: 2024-12-10 Ingested: 2026-08-02 12:03 AM Cureus
AI -
Standard 64.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 64.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 49.0; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

C
AI -
Standard 64.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 64.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 29.0; sample size: 60.0; recency: 90.0; abstract quality: 100.0.

C
Risk of late radiation necrosis more than 5 years after stereotactic radiosurgery.
PMID 39486061 Published: 2024-11-01 Ingested: 2026-08-02 12:02 AM Journal of neurosurgery
AI -
Standard 64.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 64.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 24.0; sample size: 70.0; recency: 90.0; abstract quality: 100.0.

C
AI -
Standard 64.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 64.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 34.0; sample size: 50.0; recency: 90.0; abstract quality: 100.0.

C
AI -
Standard 64.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 64.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 34.0; sample size: 50.0; recency: 90.0; abstract quality: 100.0.

C
Is it Cellulitis Again? Erythema Concerning for Infection in Children With High-Risk Solid Tumors Who Have a Gastrostomy Tube.
PMID 39328889 Published: 2024-09-01 Ingested: 2026-08-02 12:02 AM Journal of the advanced practitioner in oncology
AI -
Standard 64.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 64.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 34.0; sample size: 50.0; recency: 90.0; abstract quality: 100.0.

C
SAPHO syndrome in the mandible: A 17-patient-based experience.
PMID 39214251 Published: 2024-08-29 Ingested: 2026-08-02 12:01 AM Journal of stomatology, oral and maxillofacial surgery
AI -
Standard 64.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 64.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 44.0; sample size: 30.0; recency: 90.0; abstract quality: 100.0.

C
AI -
Standard 64.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 64.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 44.0; sample size: 30.0; recency: 90.0; abstract quality: 100.0.

Previous
Page 1204 of 3244
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic